Parkman Healthcare Partners LLC Pulmonx Corp Transaction History
Parkman Healthcare Partners LLC
- $708 Million
- Q3 2024
A detailed history of Parkman Healthcare Partners LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 206,444 shares of LUNG stock, worth $1.28 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
206,444Holding current value
$1.28 Million% of portfolio
0.24%Shares
1 transactions
Others Institutions Holding LUNG
# of Institutions
124Shares Held
31MCall Options Held
300Put Options Held
204K-
Primecap Management CO Pasadena, CA5.68MShares$35.2 Million0.04% of portfolio
-
Morgan Stanley New York, NY3.79MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$14.1 Million0.0% of portfolio
-
Jefferies Group LLC New York, NY1.2MShares$7.45 Million0.2% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $231M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...